Reply To: Traders Market Weekly: NVidia, AI and The Debt Celling

#58657
Truman
Participant

Horizon Therapeutics (HZNP 92.95, -19.30, -17.2%): FTC will soon challenge Amgen (AMGN) acquisition of Horizon Therapeutics (HZNP), according to Bloomberg